The tour begins September 9 at the Citi Biopharma Back to School Conference, followed by the Cantor Global Healthcare Conference on September 10, where Schorno is set to deliver a company overview at 11:30 a.m. ET. The series concludes on September 15 at the H.C. Wainwright 28th Annual Global Investment Conference, featuring a 10:00 a.m. ET presentation.

Investors can access live webcasts and archived recordings for the Cantor and H.C. Wainwright sessions via the company’s investor relations portal. Based in South San Francisco, Rigel continues its focus on developing therapies for hematologic disorders and oncology, maintaining its presence in the commercial-stage biotech sector since its founding in 1996.